Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin

European Journal of Endocrinology

Volumn 145, Issue 5, 2001, Pages 651-658

  Grundker C ^a   Schlotawa, L ^a   Viereck, V ^a   Emons, G ^a  

^a Dept of Gynaecology/Obstetrics ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GONADORELIN; GONADORELIN AGONIST; GONADORELIN RECEPTOR; GONADOTROPIN; GROWTH FACTOR RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PERTUSSIS TOXIN; PROTEIN C JUN; PROTEIN KINASE C; PROTEIN TYROSINE PHOSPHATASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRIPTORELIN;

ARTICLE; ASSAY; AUTOCRINE EFFECT; CANCER CELL CULTURE; CELL PROLIFERATION; CELL PROTECTION; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; ENDOMETRIUM CANCER; ENZYME ACTIVATION; ENZYME ACTIVITY; GONADORELIN RELEASE; HUMAN; HUMAN CELL; INCUBATION TIME; MITOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 0035171066     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1450651     Document Type: Article

References (51)

1. Gonadotropin-releasing hormone and its analogues
2. Hypothalamic hormones from neuroendocrinology to cancer therapy
3. Gonadotropin gene modulation by steroids and gonadotropin-releasing hormone
4. 11
5. Expression and signal transduction pathways of gonadotropin-releasing hormone receptors
6. 2+ and protein kinase C
7. Expression of gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor mRNAs in various non-reproductive human tissues
8. Expression of human gonadotropin-releasing hormone receptor gene in the placenta and its functional relationship to human chorionic gonadotropin secretion
9. Gonadotropin-releasing hormone receptor gene expression in human ovary and granulosa-lutein cells
10. Gonadotropin-releasing hormone (GnRH) and GnRH receptor gene expression in human myometrium and leiomyomata and the direct action of GnRH analogs on myometrial smooth muscle cells and interaction with ovarian steroids in vitro
11. Growth-inhibitory actions of luteinizing hormone releasing hormone on tumor cells
12. Luteinizing hormone-releasing hormone (LHRH) might act as a negative autocrine regulator of proliferation of human ovarian cancer
13. Presence and characteristics of receptors for [D-Trp6]luteinizing hormone releasing hormone and epidermal growth factor in human ovarian cancer
14. The expression of gonadotropin-releasing hormone and its receptor in endometrial cancer and its relevance as an autocrine growth factor
15. Expression of the mRNA for gonadotropin-releasing hormone and its receptor in human cancer cell lines
16. 6]-luteinizing-hormone-releasing hormone, somatostatin, epidermal growth factor and sex steroids in 500 biopsy samples of human breast cancer
17. Antiproliferative effects of luteinizing hormone-releasing hormone (LHRH) agonists on human androgen-independent prostate cancer cell line DU 145: Evidence for an autocrine-inhibitory LHRH loop
18. Mechanism of GnRH receptor signaling: From the membrane to the nucleus
19. Luteinizing hormone-releasing hormone agonist triptorelin antagonizes signal transduction and mitogenic activity of epidermal growth factor in human ovarian and endometrial cancer cell lines
20. Luteinizing hormone-releasing hormone (LHRH) agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers
21. Luteinizing hormone-releasing hormone induces nuclear factor κB-activation and inhibits apoptosis in ovarian cancer cells
22. Oncogenic conversion by regulatory changes in transcription factors
23. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation
24. Mouse JunD negatively regulates fibroblast growth and antagonizes transformation by ras
25. Differential regulation of JunD by dihydroxycholecalciferol in human chronic myelogenous leukemia cells
26. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function
27. Activation of the serum response factor by p65/NF-kappaB
28. Establishment of a new endometrial adenocarcinoma cell line. Ishikawa cells, containing estrogen and progesterone receptors
29. Establishment of a cell line of human endometrial adenocarcinoma in vitro
30. High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines
31. CD95 (APO-1/Fas) induces activation of SAP kinases downstream of ICE-like proteases
32. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
33. The small GTP-binding proteins Rac1 and Cdc42 regulate the activity of the JNK/SAPK signaling pathway
34. AP-1: One switch for many signals
35. Stimulation of Jun N-terminal kinase (JNK) by gonadotropin-releasing hormone in pituitary αT3-1 cell line is mediated by protein kinase C, c.Src, and CDC-42
36. MAPKs: New JNK expands the group
37. The regulation of AP-1 activity by mitogen-activated protein kinases
38. Luteinizing hormone-releasing hormone agonists interfere with the stimulatory actions of epidermal growth factor in human prostatic cancer cell lines LNCaP and DU 145
39. G(i)-dependent activation of c-Jun N-terminal kinase in human embryonal kidney 293 cell
40. Activation of MAPK cascades by G-protein-coupled receptors: The case of gonadotropin-releasing hormone receptor
41. Lysophosphatidylcholine stimulates activator protein 1 and the c-Jun N-terminal kinase activity
42. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun
43. Analysis of AP-1 function in cellular transformation pathways
44. The Tpl-2 protooncoprotein activates the nuclear factor of activated T cells and induces interleukin 2 expression in T cell lines
45. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB
46. A mammalian scaffold complex that selectively mediates MAP kinase activation
47. Integration of MAP kinase signal transduction pathways at the serum response element
48. Involvement of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase in α1B-adrenergic receptor/Gαq-induced inhibition of cell proliferation
49. Differentially regulated immediate early genes in the rat uterus
50. Regulation of UT-OC-3 ovarian carcinoma cells by cytokines: Inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-kappaB
51. c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms